![](/img/cover-not-exists.png)
P1.01-02 Long-Term Outcomes with First-Line Nivolumab Plus Ipilimumab in Advanced NSCLC: 3-Year Follow-Up from CheckMate 012
Antonia, S., Gettinger, S., Borghaei, H., Goldman, J.W., Brahmer, J., Ready, N., Gerber, D., Chow, L., Juergens, R., Laurie, S., Shepherd, F., Li, X., Li, A., Geese, W., Hellmann, M.Volume:
13
Language:
english
Journal:
Journal of Thoracic Oncology
DOI:
10.1016/J.JTHO.2018.08.558
Date:
October, 2018
File:
PDF, 185 KB
english, 2018